Acquired somatic ATRX mutations in myelodysplastic syndrome associated with alpha thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations
- PMID: 14592816
- DOI: 10.1182/blood-2003-09-3360
Acquired somatic ATRX mutations in myelodysplastic syndrome associated with alpha thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations
Abstract
Acquired somatic mutations in ATRX, an X-linked gene encoding a chromatin-associated protein, were recently identified in 4 patients with the rare subtype of myelodysplastic syndrome (MDS) associated with thalassemia (ATMDS). Here we describe a series of novel point mutations in ATRX detected in archival DNA samples from marrow and/or blood of patients with ATMDS by use of denaturing high-performance liquid chromatography (DHPLC), a technique sensitive to low-level mosaicism. Two of the new mutations result in changes in amino acids altered in previously described pedigrees with germ line ATRX mutations (ATR-X syndrome), but the hematologic abnormalities were much more severe in the patients with ATMDS than in the corresponding constitutional cases. In one ATMDS case where DNA samples from several time points were available, the proportion of ATRX-mutant subclones correlated with changes in the amount of hemoglobin H. This study strengthens the link between acquired, somatic ATRX mutations and ATMDS, illustrates how molecular defects associated with MDS and other hematologic malignancies masked by somatic mosaicism may be detected by DHPLC, and shows that additional factors increase the severity of the hematologic phenotype of ATRX mutations in ATMDS.
Similar articles
-
Incidence of ATRX mutations in myelodysplastic syndromes, the value of microcytosis.Am J Hematol. 2015 Aug;90(8):737-8. doi: 10.1002/ajh.24073. Am J Hematol. 2015. PMID: 26017030
-
The role of X-inactivation in the gender bias of patients with acquired alpha-thalassaemia and myelodysplastic syndrome (ATMDS).Br J Haematol. 2009 Feb;144(4):538-45. doi: 10.1111/j.1365-2141.2008.07505.x. Br J Haematol. 2009. PMID: 19055664
-
A new ATRX mutation in a patient with acquired α-thalassemia myelodysplastic syndrome.Hemoglobin. 2012;36(6):581-5. doi: 10.3109/03630269.2012.724040. Epub 2012 Oct 24. Hemoglobin. 2012. PMID: 23092150
-
De novo and acquired forms of alpha thalassemia.Curr Hematol Rep. 2006 Mar;5(1):11-4. Curr Hematol Rep. 2006. PMID: 16537041 Review.
-
[X-linked alpha-thalassemia/mental retardation syndrome].Rinsho Byori. 2009 Apr;57(4):382-90. Rinsho Byori. 2009. PMID: 19489441 Review. Japanese.
Cited by
-
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.Blood. 2015 Jul 2;126(1):9-16. doi: 10.1182/blood-2015-03-631747. Epub 2015 Apr 30. Blood. 2015. PMID: 25931582 Free PMC article.
-
Compromised genomic integrity impedes muscle growth after Atrx inactivation.J Clin Invest. 2012 Dec;122(12):4412-23. doi: 10.1172/JCI63765. Epub 2012 Nov 1. J Clin Invest. 2012. PMID: 23114596 Free PMC article.
-
Genetic basis of myelodysplastic syndromes.Proc Jpn Acad Ser B Phys Biol Sci. 2020;96(3):107-121. doi: 10.2183/pjab.96.009. Proc Jpn Acad Ser B Phys Biol Sci. 2020. PMID: 32161209 Free PMC article. Review.
-
Loss of atrx cooperates with p53-deficiency to promote the development of sarcomas and other malignancies.PLoS Genet. 2019 Apr 10;15(4):e1008039. doi: 10.1371/journal.pgen.1008039. eCollection 2019 Apr. PLoS Genet. 2019. PMID: 30970016 Free PMC article.
-
The Chromatin Remodeler ATRX: Role and Mechanism in Biology and Cancer.Cancers (Basel). 2023 Apr 10;15(8):2228. doi: 10.3390/cancers15082228. Cancers (Basel). 2023. PMID: 37190157 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous